InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: None

Saturday, 12/23/2017 10:28:10 PM

Saturday, December 23, 2017 10:28:10 PM

Post# of 29174
If the CanniMed proxy is successful at getting the shareholders to reject the ACB deal, then for several reasons, there’s going to be some disappointment shared by many. jmo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.